Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of the disease risk index for outcome of patients undergoing allogeneic hematopoietic stem cell transplantation after T cell depletion.
Beauverd Y, Roosnek E, Tirefort Y, Nagy-Hulliger M, Bernimoulin M, Tsopra O, Ansari M, Dantin C, Casini A, Grandjean AP, Chigrinova E, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: dantin c. Biol Blood Marrow Transplant. 2014 Sep;20(9):1322-8. doi: 10.1016/j.bbmt.2014.04.023. Epub 2014 Apr 24. Biol Blood Marrow Transplant. 2014. PMID: 24769318 Free article.
FLT3-ITD mutations do not impact the outcome of patients allografted with partial T-cell depleted grafts for AML with normal cytogenetics in first complete remission.
Beauverd Y, Tsopra O, Roosnek E, Simon A, Grandjean AP, Tirefort Y, Dantin C, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: dantin c. Hematol Oncol. 2017 Sep;35(3):392-394. doi: 10.1002/hon.2272. Epub 2015 Nov 13. Hematol Oncol. 2017. PMID: 26563907 No abstract available.
Outcome of hematopoietic stem cell transplantation is similar for patients with a partial in vitro T-cell-depleted graft compared with a non-T-cell-depleted graft when stratified by the refined disease risk index.
Beauverd Y, Roosnek E, Tirefort Y, Dantin C, Ansari M, Tsopra O, Masouridi-Levrat S, Chalandon Y. Beauverd Y, et al. Among authors: dantin c. Bone Marrow Transplant. 2016 Jul;51(7):955-60. doi: 10.1038/bmt.2016.34. Epub 2016 Mar 7. Bone Marrow Transplant. 2016. PMID: 26950373 Free article.
Partial T-cell depletion improves the composite endpoint graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation.
Simonetta F, Masouridi-Levrat S, Beauverd Y, Tsopra O, Tirefort Y, Koutsi A, Stephan C, Polchlopek-Blasiak K, Pradier A, Dantin C, Ansari M, Roosnek E, Chalandon Y. Simonetta F, et al. Among authors: dantin c. Leuk Lymphoma. 2018 Mar;59(3):590-600. doi: 10.1080/10428194.2017.1344844. Epub 2017 Jul 6. Leuk Lymphoma. 2018. PMID: 28679328
Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome.
Raboud M, Beauverd Y, Simonetta F, Dantin C, Pradier A, Tsopra O, Koutsi A, Mamez AC, Stephan C, Rodriguez Morales JF, Polchlopek-Blasiak K, Tirefort Y, Masouridi-Levrat S, Chalandon Y. Raboud M, et al. Among authors: dantin c. Bone Marrow Transplant. 2018 Aug;53(8):1072-1075. doi: 10.1038/s41409-018-0136-2. Epub 2018 Mar 7. Bone Marrow Transplant. 2018. PMID: 29515245 No abstract available.
Human pegivirus persistence in human blood virome after allogeneic haematopoietic stem-cell transplantation.
Vu DL, Cordey S, Simonetta F, Brito F, Docquier M, Turin L, van Delden C, Boely E, Dantin C, Pradier A, Roosnek E, Chalandon Y, Zdobnov EM, Masouridi-Levrat S, Kaiser L. Vu DL, et al. Among authors: dantin c. Clin Microbiol Infect. 2019 Feb;25(2):225-232. doi: 10.1016/j.cmi.2018.05.004. Epub 2018 May 19. Clin Microbiol Infect. 2019. PMID: 29787887 Free article.
21 results